Viking Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Viking Therapeutics, Inc.‘s stocks are currently a part of 130 hedge funds’ portfolios, which represents 43.23% of the total amount of its stocks outstanding. This makes up a total of 31.01M shares of Viking Therapeutics, Inc.. Compared to the previous quarter, the number fell by -14.31% or -5.17M shares fewer. As for the holding position changes, 33.08% (43) of current hedge fund investors increased the number of shares held, 25.38% (33) of current holders sold a part of the shares held, and 13.85% (18) closed the holdings completely. 19 hedge funds are new holders of Viking Therapeutics, Inc. stock in Q1 2022, it is 14.62% of total holders.
Hedge funds holding Viking Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 12 |
|---|---|
| Q3 2017 | 17 |
| Q4 2017 | 33 |
| Q1 2018 | 64 |
| Q2 2018 | 116 |
| Q3 2018 | 149 |
| Q4 2018 | 165 |
| Q1 2019 | 163 |
| Q2 2019 | 155 |
| Q3 2019 | 143 |
| Q4 2019 | 140 |
| Q1 2020 | 131 |
| Q2 2020 | 136 |
| Q3 2020 | 137 |
| Q4 2020 | 138 |
| Q1 2021 | 140 |
| Q2 2021 | 133 |
| Q3 2021 | 128 |
| Q4 2021 | 131 |
| Q1 2022 | 130 |
Hedge funds changes in Viking Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 3 | 2 | 1 | 3 | 3 |
|---|---|---|---|---|---|
| Q3 2017 | 8 | 2 | 1 | 2 | 4 |
| Q4 2017 | 23 | 7 | 1 | 7 | -5 |
| Q1 2018 | 35 | 15 | 7 | 4 | 3 |
| Q2 2018 | 69 | 28 | 13 | 16 | -10 |
| Q3 2018 | 54 | 55 | 32 | 20 | -12 |
| Q4 2018 | 51 | 70 | 37 | 33 | -26 |
| Q1 2019 | 26 | 58 | 45 | 29 | 5 |
| Q2 2019 | 21 | 49 | 43 | 24 | 18 |
| Q3 2019 | 14 | 48 | 42 | 26 | 13 |
| Q4 2019 | 25 | 39 | 44 | 25 | 7 |
| Q1 2020 | 20 | 39 | 39 | 27 | 6 |
| Q2 2020 | 21 | 42 | 45 | 16 | 12 |
| Q3 2020 | 16 | 34 | 48 | 14 | 25 |
| Q4 2020 | 18 | 44 | 48 | 19 | 9 |
| Q1 2021 | 21 | 49 | 44 | 17 | 9 |
| Q2 2021 | 13 | 39 | 51 | 19 | 11 |
| Q3 2021 | 8 | 40 | 45 | 13 | 22 |
| Q4 2021 | 29 | 37 | 36 | 26 | 3 |
| Q1 2022 | 19 | 43 | 33 | 18 | 17 |
Hedge funds changes in Viking Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 622,000 | 214,000 |
| Q2 2018 | 4,941,000 | 7,402,000 |
| Q3 2018 | 21,235,000 | 36,950,000 |
| Q4 2018 | 5,835,000 | 6,589,000 |
| Q1 2019 | 23,561,000 | 18,012,000 |
| Q2 2019 | 16,535,000 | 12,331,000 |
| Q3 2019 | 14,887,000 | 7,815,000 |
| Q4 2019 | 12,307,000 | 10,966,000 |
| Q1 2020 | 4,124,000 | 2,370,000 |
| Q2 2020 | 9,400,000 | 3,499,000 |
| Q3 2020 | 5,184,000 | 2,761,000 |
| Q4 2020 | 3,221,000 | 2,867,000 |
| Q1 2021 | 4,389,000 | 2,193,000 |
| Q2 2021 | 2,553,000 | 1,700,000 |
| Q3 2021 | 3,483,000 | 1,558,000 |
| Q4 2021 | 1,073,000 | 933,000 |
| Q1 2022 | 475,000 | 637,000 |